11-617595-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_021924.5(CDHR5):āc.2294C>Gā(p.Ala765Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,455,628 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_021924.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDHR5 | NM_021924.5 | c.2294C>G | p.Ala765Gly | missense_variant | 15/15 | ENST00000397542.7 | NP_068743.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CDHR5 | ENST00000397542.7 | c.2294C>G | p.Ala765Gly | missense_variant | 15/15 | 1 | NM_021924.5 | ENSP00000380676.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000868 AC: 2AN: 230398Hom.: 0 AF XY: 0.0000157 AC XY: 2AN XY: 127342
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1455628Hom.: 0 Cov.: 36 AF XY: 0.00000276 AC XY: 2AN XY: 723940
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 29, 2024 | The c.2294C>G (p.A765G) alteration is located in exon 15 (coding exon 15) of the CDHR5 gene. This alteration results from a C to G substitution at nucleotide position 2294, causing the alanine (A) at amino acid position 765 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at